Alzheimer Disease, Early Onset Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Alzheimer Disease, Early Onset
Denali Therapeutics Inc.68 enrolled1 locationNCT07328451
Recruiting
Phase 1
A Study to Assess THN391 in Subjects With Alzheimer's Disease
Alzheimer Disease, Early Onset
Therini Bio, Inc.15 enrolled4 locationsNCT06814730